Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030)

NCT04515641 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV) Infection

Interventions

DRUG: Islatravir

Sponsor

Merck Sharp & Dohme LLC